Genetic variation in the glucose-dependent insulinotropic polypeptide receptor modifies the association between carbohydrate and fat intake and risk of type 2 diabetes in the Malmo diet and Cancer cohort

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 5, 2012, Pages

  Sonestedt, Emily ^a   Lyssenko, Valeriya ^a   Ericson, Ulrika ^a   Gullberg, Bo ^a   Wirfält, Elisabet ^a   Groop, Leif ^a   Orho Melander, Marju ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR; HORMONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CARBOHYDRATE INTAKE; COHORT ANALYSIS; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GIPR GENE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; ALLELES; BODY COMPOSITION; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; FEMALE; FOLLOW-UP STUDIES; GENE-ENVIRONMENT INTERACTION; GENETIC VARIATION; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RECEPTORS, GASTROINTESTINAL HORMONE;

MUS;

EID: 84860733554     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2444     Document Type: Article

References (41)

1. Karhunen LJ, Juvonen KR, Huotari A, Purhonen AK, Herzig KH 2008 Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regul Pept 149:70-78
2. Nilsson M, Stenberg M, Frid AH, Holst JJ, Björck IM 2004 Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr 80:1246-1253
3. Carr RD, Larsen MO, Winzell MS, Jelic K, Lindgren O, Deacon CF, Ahrén B 2008 Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Am J Physiol Endocrinol Metab 295:E779-E784
4. Irwin N, Flatt PR 2009 Therapeutic potential for GIP receptor agonists and antagonists. Best Pract Res Clin Endocrinol Metab 23:499-512
5. Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Lyssenko V, Bouatia-Naji N, Dupuis J, Jackson AU, Kao WH, Li M, Glazer NL, Manning AK, Luan J, Stringham HM, Prokopenko I, Johnson T, Grarup N, Boesgaard TW, Lecoeur C, Shrader P, O'Connell J, Ingelsson E, Couper DJ, Rice K, et al. 2010 Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 42:142-148
6. Lyssenko V, Eliasson L, Kotova O, Pilgaard K, Wierup N, Salehi A, Wendt A, Jonsson A, De Marinis YZ, Berglund LM, Taneera J, Balhuizen A, Hansson O, Osmark P, Dunér P, Brøns C, Stancáková A, Kuusisto J, Bugliani M, Saxena R, Ahlqvist E, Kieffer TJ, Tuomi T, Isomaa B, Melander O, et al. 2011 Pleiotropic Effects of GIP on Islet Function Involve Osteopontin. Diabetes 60:2424-2433
7. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y 2002 Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8:738-742
8. Flatt PR 2008 Dorothy Hodgkin Lecture 2008. Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesitydiabetes? Diabet Med 25:759-764
9. Gault VA, McClean PL, Cassidy RS, Irwin N, Flatt PR 2007 Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia 50:1752-1762
10. McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR 2007 GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Am J Physiol Endocrinol Metab 293:E1746-E1755
11. Schulze MB, Hu FB 2005 Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health 26:445-467
12. Berglund G, Elmstähl S, Janzon L, Larsson SA 1993 The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med 233:45-51
13. Manjer J, Elmståhl S, Janzon L, Berglund G 2002 Invitation to a population-based cohort study: differences between subjects recruited using various strategies. Scand J Public Health 30:103-112
14. Manjer J, Carlsson S, Elmståhl S, Gullberg B, Janzon L, Lindström M, Mattisson I, Berglund G 2001 The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 10:489-499
15. Hedblad B, Nilsson P, Engström G, Berglund G, Janzon L 2002 Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 19:470-475
16. Wirfält E, Mattisson I, Johansson U, Gullberg B, Wallström P, Berglund G 2002 A methodological report from the Malmo Diet and Cancer study: development and evaluation of altered routines in dietary data processing. Nutr J 1:3
17. Riboli E, Elmstahl S, Saracci R, Gullberg B, Lindgarde F 1997 The Malmo Food Study: validity of two dietary assessment methods for measuring nutrient intake. Int J Epidemiol 26(Suppl 1):S161-S173
18. Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Nilsson PM, Gudbjörnsdottir S 2008 Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care 31:2038-2043
19. Lindholm E, Agardh E, Tuomi T, Groop L, Agardh CD 2001 Classifying diabetes according to the new WHO clinical stages. Eur J Epidemiol 17:983-989
20. Enhörning S, Wang TJ, Nilsson PM, Almgren P, Hedblad B, Berglund G, Struck J, Morgenthaler NG, Bergmann A, Lindholm E, Groop L, Lyssenko V, Orho-Melander M, Newton-Cheh C, Melander O 2010 Plasma copeptin and the risk of diabetes mellitus. Circulation 121:2102-2108
21. Hanas R, John G 2010 2010 consensus statement onthe worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 33:1903-1904
22. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, Mosca A, Mauri P, Paroni R, Susanto F, Takei I, Thienpont L, Umemoto M, Wiedmeyer HM 2004 IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166-174
23. Tong Y, Lin Y, Zhang Y, Yang J, Zhang Y, Liu H, Zhang B 2009 Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 10:15
24. Mattisson I, Wirfält E, Aronsson CA, Wallström P, Sonestedt E, Gullberg B, Berglund G 2005 Misreporting of energy: prevalence, characteristics of misreporters and influence on observed risk estimates inthe Malmo Diet and Cancer cohort. Br JNutr 94:832-842
25. Szklo M, Nieto FJ 2007 Epidemiology: beyond the basics. Sudbury, MA: Jones and Bartlett
26. Sonestedt E, Gullberg B, Wirfält E 2007 Both food habit change in the past and obesity status may influence the association between dietary factors and postmenopausal breast cancer. Public Health Nutr 10:769-779
27. Manolio TA, Bailey-Wilson JE, Collins FS 2006 Genes, environment and the value of prospective cohort studies. Nat Rev Genet 7:812-820
28. Thomas D 2010 Gene-environment-wide association studies: emerging approaches. Nat Rev Genet 11:259-272
29. Burton PR, Hansell AL, Fortier I, Manolio TA, Khoury MJ, Little J, Elliott P 2009 Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol 38:263-273
30. Gauderman WJ 2002 Sample size requirements for matched casecontrol studies of gene-environment interaction. Stat Med 21:35-50
31. Lamri A, Abi Khalil C, Jaziri R, Velho G, Lantieri O, Vol S, Froguel P, Balkau B, Marre M, Fumeron F 2011 Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D. E. S. I. R. prospective study. Int J Obes (Lond) 36:218-224
32. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, Allen HL, Lindgren CM, Luan J, Mägi R, Randall JC, Vedantam S, Winkler TW, Qi L, Workalemahu T, Heid IM, Steinthorsdottir V, Stringham HM, Weedon MN, Wheeler E, Wood AR, Ferreira T, Weyant RJ, Segrè AV, Estrada K, et al. 2010 Association analysesof249, 796 individuals reveal18 new loci associated with body mass index. Nat Genet 42:937-948
33. Fortin JP, Schroeder JC, Zhu Y, Beinborn M, Kopin AS 2010 Pharmacological characterization of human incretin receptor missense variants. J Pharmacol Exp Ther 332:274-280
34. 3) GIP improves metabolic status in high-fat-fed mice. Diabetes Obes Metab 12:744-751
35. Callmer E, Riboli E, Saracci R, Akesson B, Lindgärde F 1993 Dietary assessment methods evaluated in the Malmo food study. J Intern Med 233:53-57
36. Atkinson FS, Foster-Powell K, Brand-Miller JC 2008 International tables of glycemic index and glycemic load values: 2008. Diabetes Care 31:2281-2283
37. van Bakel MM, Slimani N, Feskens EJ, Du H, Beulens JW, van der Schouw YT, Brighenti F, Halkjaer J, Cust AE, Ferrari P, Brand-Miller J, Bueno-de-Mesquita HB, Peeters P, Ardanaz E, Dorronsoro M, Crowe FL, Bingham S, Rohrmann S, Boeing H, Johansson I, Manjer J, Tjonneland A, Overvad K, Lund E, Skeie G, et al. 2009 Methodological challenges in the application of the glycemic index in epidemiological studies using data from the European Prospective Investigation into Cancer and Nutrition. J Nutr 139:568-575
38. Isken F, Weickert MO, Tschöp MH, Nogueiras R, Möhlig M, Abdelrahman A, Klaus S, Thorens B, Pfeiffer AF 2009 Metabolic effects of diets differing in glycaemic index depend on age and endogenous glucose-dependent insulinotrophic polypeptide in mice. Diabetologia 52:2159-2168
39. Isomaa B, Forsén B, Lahti K, Holmström N, Wadén J, Matintupa O, Almgren P, Eriksson JG, Lyssenko V, Taskinen MR, Tuomi T, Groop LC 2010 A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia 53:1709-1713
40. Halton TL, Liu S, Manson JE, Hu FB 2008 Low-carbohydrate-diet score and risk of type 2 diabetes in women. Am J Clin Nutr 87:339-346
41. Hu FB, van Dam RM, Liu S 2001 Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 44:805-817